| Oct 1 |
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
|
| Oct 1 |
Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
|
| Sep 29 |
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
|
| Sep 26 |
Alnylam to Webcast TTR Investor Day
|
| Sep 19 |
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
|
| Sep 19 |
High Growth Tech Stocks To Watch In September 2024
|
| Sep 14 |
Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock
|
| Sep 13 |
Three Stocks That Might Be Undervalued In September 2024
|
| Sep 12 |
The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
|
| Sep 8 |
Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?
|
